Decades-Old Cancer Vaccine Offers Hope
An astonishing two-decade-old breast cancer vaccine trial has revealed that all participants with metastatic disease are still alive, a remarkable outcome that has reignited interest in cancer vaccine development. Researchers discovered these survivors possess powerful, long-lasting immune memory cells with a specific CD27 marker, suggesting a crucial blueprint for next-generation immunotherapies.